Home/Pipeline/Neuropathic Pain Model Service

Neuropathic Pain Model Service

Neuropathic Pain

Pre-clinicalActive

Key Facts

Indication

Neuropathic Pain

Phase

Pre-clinical

Status

Active

Company

NeuroProof

About NeuroProof

NeuroProof is a neuroscience-focused CRO based in Göttingen, Germany, offering specialized pre-clinical screening services. Its core platform combines Microelectrode Array (MEA) recordings of neuronal network activity with advanced data analysis and pattern recognition to model neurological diseases and assess compound effects. The company serves pharmaceutical and biotech clients by providing phenotypic assays, neurotoxicity evaluations, and custom disease models, primarily using iPSC-derived neurons, to accelerate CNS drug development and reduce reliance on animal testing.

View full company profile

Therapeutic Areas

Alzheimer's Disease Parkinson's Disease Epilepsy Amyotrophic Lateral Sclerosis Schizophrenia Neuropathic Pain Fragile X Syndrome Neurotoxicity

Other Neuropathic Pain Drugs

Drug	Company	Phase	Status
Peripheral nerve pain agent	Nyrada	Preclinical	Active
NTRX-07	NeuroTherapia	Pre-clinical	Active
Sana Device for Neuropathic Pain	Sana Health	Pivotal Trial Completed	Active
Neuropathic Pain Program	VersaPeutics	Preclinical	Active
Cerebro Platform for Pain	Vonova.io	Pre-clinical	Active
LAT9997	Lateral Pharma	Phase 2 (next-gen)	Active; composition-of-matter patent secured
ZYNPN	Zyneyro	Pre-clinical	Active
XT-150 (Preclinical)	Xalud Therapeutics	Preclinical	Active
ONO-2910	Ono Pharmaceutical	Phase 2	Active
VX-548	Vertex Pharmaceuticals	Phase 2	Active
BDT272	KYORIN Pharmaceutical	Preclinical	Active (In-licensed)
HSK16149	Haisco Pharmaceutical Group	Phase III	Active